Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 50/100 MG/DAY IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Bacterial Infections and Mycoses [C01] | |||||
Brands: Please see report, Please see report, Please see report, Please see report | |||||
MAH holders: Please see report, Please see report, Please see report | |||||
Assessment: | |||||
Active substance: FLUCONAZOLE | |||||
ATC code: | |||||
Document link: | |||||
Document date: | |||||
Study number: FCA-NY-87-002* | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |